• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "帕金森病" 61 results
        • Visual field analysis in early mild Parkinson's disease

          ObjectiveTo evaluate visual field changes in early mild Parkinson's disease. Methods A total of 66 eyes of 33 cases with early mild Parkinson's disease and 72 eyes of 36 age-matched normal individuals were enrolled into the study. Humphrey Field Analyzer II was applied for central visual field test. The visual field indices of mean deviation (MD) and pattern standard deviation (PSD) were analyzed to evaluate the location and the characteristics of visual field defect in this study. ResultsVisual field indices MD (-3.4±2.5) dB was significantly changed in patients with PD when compared to the controls (-0.6±1.7) dB. PSD (4.3±2.6) was significantly higher in patients with PD than that in the control group (2.1±1.8) dB. Glaucoma hemifield test (GHT) assessment was within normal limits in the controls. Of the 33 patients (66 eyes) in PD, GHT showed outside normal limits in 31 eyes, borderline in 8 eyes, and within normal limits in 27 eyes. 31 eyes outside normal limits appeared glaucomatous visual field defects, in which 16 with nasal step and 5 with arcuate defect. ConclusionsVisual field indices including MD and PSD in early mild patients with PD were significantly worse than that in the controls group. GHT abnormalities could be found in early mild PD patients with visual field defects, including pericentral scotoma and nasal step, which mimicked glaucomatous changes.

          Release date: Export PDF Favorites Scan
        • 帕金森病合并痛風致關節潰瘍護理一例

          Release date:2016-09-08 09:27 Export PDF Favorites Scan
        • Frailty status and its influencing factors in elderly Parkinson’s disease patients

          Objective To understand the frailty status and main influencing factors of elderly Parkinson’s disease (PD) patients. Methods The elderly PD patients who attended the Department of Neurology of Changshu Hospital of Traditional Chinese Medicine between November 2023 and March 2024 were selected. The patients’ frailty conditions were investigated using general information questionnaire, Chinese version of Tilburg Frailty Indicator, Hoehn-Yahr Rating Scale, Mini-Nutritional Assessment Short Form, Movement Disorder Society-Unified PD Rating Scale Part Ⅲ, PD Sleep Scale-2, and Mini-Mental State Examination. Multiple linear regression analysis was used to further determine the influencing factors of the frailty status in elderly PD patients. Results A total of 170 PD patients were included. Among them, 117 cases (68.82%) had frailty, while 53 cases (31.18%) had not frailty. The average score for frailty was (6.48±3.34) points, the average score for nutritional status was (11.89±1.65) points, the average score for motor function was (27.40±13.73) points, the average score for sleep quality was (16.05±7.76) points, and the average score for cognitive status is (26.25±4.51) points. The Pearson correlation analysis results showed that PD patient frailty was positively correlated with motor function and sleep quality (P<0.01), and negatively correlated with nutritional status and cognitive status (P<0.01). The results of multiple linear regression analysis showed that age, education, place of residence, course of disease, Hoehn-Yahr Rating, nutritional status, motor function, cognitive status and sleep quality were the influencing factors of frailty in PD patients (P<0.05). Conclusions Elderly PD patients are prone to frailty. Healthcare professionals should pay attention to early screening for frailty in this population and provide timely and effective interventions to prevent or delay the onset of frailty in patients.

          Release date:2025-05-26 04:29 Export PDF Favorites Scan
        • 小膠質細胞與帕金森病

          神經炎性反應尤其是小膠質細胞活化在帕金森病(Parkinson’s disease,PD)患者多巴胺神經元退變中發揮重要作用。活化的小膠質細胞釋放多種炎性因子導致多巴胺神經元死亡。對小膠質細胞活化引起多巴胺神經元死亡的機制研究發現,抑制小膠質細胞活化的藥物對多巴胺神經元具有保護作用。抑制小膠質細胞活化的抗炎治療將成為PD治療的新靶點之一。

          Release date:2016-09-08 09:47 Export PDF Favorites Scan
        • Evidence-Based Treatment for Advanced Parkinson’ s Disease

          Evidence has been retrieved through MEDLINE and Cochrane Libray about the treatment for patients with advanced Parkinson’s disease who suffered from on-off, dyskinesia and depression after chronic use of L-dopa. All of the evidence has been evaluated. Methods of evidence-based treatment were drawn up according to the evidence, clinciams’ experiences and patients’ preferences. All symptoms of the patient have been improved obviously.

          Release date:2016-09-07 02:27 Export PDF Favorites Scan
        • Application of artificial intelligence in deep brain stimulation therapy

          Deep brain stimulation (DBS), as a major branch of functional neurosurgery, has been widely used in the treatment of diseases such as Parkinson disease, primary tremor, and muscle tone disorder. It can effectively alleviate patients’ symptoms, reduce drug dependence, and minimize adverse drug reactions. In recent years, with the rapid development of artificial intelligence (AI) in the medical field, it has gradually penetrated into multiple aspects of DBS. This article reviews the current application status of AI technology in DBS therapy and explores its future development prospects, providing new solutions for significant improvement in patients’ quality of life.

          Release date:2025-03-31 02:13 Export PDF Favorites Scan
        • 帕金森病與跌倒的研究進展

          帕金森病是一種常見的神經系統變性疾病,以靜止性震顫、肌強直、運動遲緩及姿勢步態異常為主要表現。跌倒作為晚期帕金森病患者常見且具有重要致殘性的癥狀,嚴重影響了患者的生活質量,近年來越來越受到人們的關注。基于跌倒對帕金森病患者的嚴重影響,該文將最近幾年對帕金森病伴跌倒的流行病學、危險因素、發生機制、評估、預防及治療方面的研究進行了綜述,以加深臨床醫生對帕金森病伴跌倒的重視,亦對臨床工作作出指導。

          Release date:2017-04-19 10:17 Export PDF Favorites Scan
        • The role of endogenous stem cells in central nervous system neurodegenerative diseases

          Age is the main cause of neurodegenerative changes in the central nervous system (CNS), and the loss of neurons would increase with the migration of the disease. The current treatment is also mainly used to relieve symptoms, while the function of CNS is very difficult to recover. The emergence of endogenous stem cells has brought new hope for the treatment of CNS diseases. However, this nerve regeneration is only in some specific areas, and the recovery of neural function remains unknown. More and more experts in the field of neuroscience have carried out various in vivo or in vitro experiments, in order to increase nerve regeneration and nerve function recovery through mechanism research, in the expectation that the results would be applied to the treatment of CNS diseases. This article reviews the recent progress of endogenous neural stem cells in degenerative diseases of CNS.

          Release date:2018-03-26 03:32 Export PDF Favorites Scan
        • Investigation of Anxiety Status in Family Members of Patients with Parkinson Disease

          ObjectiveTo investigate the anxiety of family members of patients with Parkinson's disease, and explore the risk factors. MethodsSelf-rating Anxiety Scale (SAS) was employed to assess a total of 107 family members of Parkinson disease patients from October 2014 to October 2015. The scores were compared with the domestic norm, and the risk factors of anxiety were analyzed with Logistic regression. ResultsThe scores of SAS (38.83±10.97) were significantly higher in patients' family members than the norm (P<0.01). Disturbance of the life and work by caring the patients, late stage of the patients, and disability of self care were independent risk factors for the anxiety of the patients' family members (P<0.01), and the three factors could increase the anxiety (OR>1). ConclusionAnxietsy exists in family members of patients with Parkinson disease. More attention should be paid when they have the factors of disturbance of the life or work by caring the patients, late stage of the patients, and self care disability of patients.

          Release date: Export PDF Favorites Scan
        • 經顱磁刺激在帕金森病患者步態異常中的應用

          經顱磁刺激(TMS)是利用變化的高毫安電流產生變化的磁場誘導的感應電場作用于顱內可興奮組織的過程。TMS以其可進行深部刺激、無痛、非介入等優點,被廣泛地應用于帕金森病的研究和治療中。目前帕金森病患者步態異常發生的病理生理機制尚不清楚,且治療十分困難。近年來TMS在對帕金森病患者步態異常的研究中得到了較大的進展。現對TMS原理以及在帕金森病患者步態異常研究及治療中的應用和進展進行綜述。

          Release date: Export PDF Favorites Scan
        7 pages Previous 1 2 3 ... 7 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜